Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies
- PMID: 37013041
- PMCID: PMC10066281
- DOI: 10.1016/j.gendis.2021.09.006
Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies
Abstract
Chronic inflammation caused by persistent infections and metabolic disorders is thought to contribute to the increased cancer risk and the accelerated cancer progression. Oppositely, acute inflammation induced by bacteria-based vaccines or that is occurring after cancer selectively inhibits cancer progression and metastasis. However, the interaction between inflammation and cancer may be more complex than the current explanations for the relationship between chronic and acute inflammation and cancer. In this review, we described the impact of inflammation on cancer on the basis of three perspectives, including inflammation with different durations (chronic and acute inflammation), different scopes (systemic and local inflammation) and different occurrence sequences (inflammation occurring after and before cancer). In addition, we also introduced bacteria/virus-based cancer immunotherapies. We perceive that inflammation may be a double-edged sword with cancer-promoting and cancer-suppressing functions in certain cases. We expect to further improve the understanding of the relationship between inflammation and cancer and provide a theoretical basis for further research on their complex interaction.
Keywords: Cancer; Duration; Inflammation; Scope; Sequence.
© 2021 The Authors. Publishing services by Elsevier B.V.
Conflict of interest statement
The authors declare no conflict of interests.
Figures
References
-
- Sharma A., Schwartz R.A., Swan K.G. Marjolin's warty ulcer. J Surg Oncol. 2011;103(2):193–195. - PubMed
-
- Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545. - PubMed
-
- Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315(26):1650–1659. - PubMed
-
- Koehne C.H., Dubois R.N. COX-2 inhibition and colorectal cancer. Semin Oncol. 2004;31(2 Suppl 7):12–21. - PubMed
-
- Flossmann E., Rothwell P.M. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007;369(9573):1603–1613. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
